A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E36.53 EPS (ttm)4.18 Insider Own0.30% Shs Outstand298.00M Perf Week0.26%
Market Cap45.18B Forward P/E24.32 EPS next Y6.28 Insider Trans-19.50% Shs Float294.18M Perf Month13.57%
Income1.25B PEG3.05 EPS next Q1.31 Inst Own90.80% Short Float / Ratio0.98% / 2.05 Perf Quarter18.10%
Sales6.85B P/S6.60 EPS this Y71.00% Inst Trans-3.24% Short Interest2.89M Perf Half Y19.64%
Book/sh17.08 P/B8.94 EPS next Y10.86% ROA12.00% Target Price160.00 Perf Year2.26%
Cash/sh3.64 P/C41.95 EPS next 5Y11.97% ROE24.30% 52W Range112.52 - 162.62 Perf YTD-4.35%
Dividend0.90 P/FCF55.50 EPS past 5Y22.90% ROI14.70% 52W High-6.47% Beta1.08
Dividend %0.59% Quick Ratio1.40 Sales past 5Y8.50% Gross Margin54.40% 52W Low35.17% ATR4.12
Employees17700 Current Ratio1.90 Sales Q/Q8.30% Oper. Margin21.40% RSI (14)57.77 Volatility2.20% 2.35%
OptionableYes Debt/Eq0.57 EPS Q/Q27.50% Profit Margin18.40% Rel Volume0.43 Prev Close152.70
ShortableYes LT Debt/Eq0.54 EarningsNov 21 AMC Payout18.90% Avg Volume1.41M Price152.10
Recom1.90 SMA202.16% SMA5010.49% SMA20017.08% Volume235,422 Change-0.40%
Aug-25-22Initiated Credit Suisse Outperform $165
Jul-20-22Initiated UBS Buy $139
Jul-08-22Downgrade Citigroup Buy → Neutral $175 → $140
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $130
Feb-23-22Reiterated Wells Fargo Overweight $180 → $160
Feb-23-22Reiterated Stifel Hold $169 → $145
Feb-23-22Reiterated Evercore ISI Outperform $170 → $155
Feb-23-22Reiterated Cowen Outperform $187 → $178
Feb-23-22Reiterated Citigroup Buy $190 → $175
Feb-23-22Reiterated BofA Securities Buy $179 → $160
Show Previous Ratings
Dec-06-22 09:00AM
Dec-05-22 08:00AM
Nov-30-22 08:00AM
Nov-29-22 03:21PM
08:00AM
04:34PM Loading…
Nov-28-22 04:34PM
06:58AM
Nov-22-22 04:41PM
02:38PM
02:32PM
06:25AM
03:04AM
Nov-21-22 05:25PM
04:42PM
04:05PM
01:36PM Loading…
01:36PM
10:52AM
10:27AM
09:12AM
Nov-19-22 07:00AM
Nov-18-22 05:09PM
02:03PM
01:36PM
07:49AM
Nov-17-22 05:04PM
02:58PM
10:56AM
Nov-16-22 04:22PM
04:05PM
03:52PM
08:47AM Loading…
08:47AM
Nov-15-22 07:00PM
04:44PM
Nov-14-22 02:12PM
10:00AM
08:00AM
07:45AM
Nov-13-22 10:39PM
Nov-10-22 11:40AM
Nov-09-22 12:37PM
12:25PM
08:58AM
Nov-08-22 03:16PM
07:49AM
Nov-07-22 08:00AM
Nov-04-22 12:33PM
09:58AM
Nov-03-22 09:45AM
Nov-01-22 02:30PM
08:05AM
Oct-31-22 09:09AM
Oct-30-22 09:36AM
Oct-18-22 07:00AM
Oct-17-22 12:18PM
09:11AM
Oct-14-22 02:19PM
02:04PM
10:31AM
09:49AM
Oct-13-22 03:04PM
09:46AM
08:42AM
Oct-12-22 05:04PM
09:30AM
08:00AM
Oct-11-22 02:00AM
Oct-05-22 06:15PM
06:37AM
Oct-04-22 08:10AM
Oct-03-22 08:00AM
Sep-29-22 01:01PM
Sep-22-22 09:10AM
Sep-21-22 04:05PM
Sep-16-22 09:30AM
Sep-15-22 11:30AM
Sep-14-22 01:48PM
Sep-12-22 08:00AM
Sep-08-22 12:32PM
Sep-07-22 03:25PM
Sep-06-22 08:46AM
Sep-05-22 01:05PM
Sep-02-22 06:20AM
Sep-01-22 08:00AM
Aug-30-22 08:42AM
Aug-29-22 06:00AM
Aug-25-22 12:46PM
09:33AM
Aug-23-22 08:38AM
Aug-22-22 08:30AM
Aug-19-22 09:45AM
06:46AM
Aug-18-22 09:48AM
09:26AM
Aug-17-22 04:31PM
02:18PM
02:02PM
01:00AM
Aug-16-22 05:25PM
04:29PM
04:05PM
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thaysen JacobSr. Vice PresidentDec 01Sale155.653,235503,52884,464Dec 02 01:45 PM
Thaysen JacobSr. Vice PresidentNov 30Sale154.639,7001,499,91287,699Dec 02 01:45 PM
FIELDS HEIDIDirectorNov 23Sale155.843,635566,48254,484Nov 28 03:47 PM
Gonsalves RodneyV.P., Corporate ControllerNov 23Sale156.204,634723,83128,447Nov 28 03:47 PM
McMullen Michael R.CEO and PresidentNov 22Option Exercise40.80128,7265,252,021389,417Nov 23 01:53 PM
MCDONNELL PADRAIGSr. Vice PresidentNov 22Sale153.212,746420,71516,201Nov 23 01:51 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 22Sale153.907,5451,161,17646,499Nov 23 01:54 PM
McMullen Michael R.CEO and PresidentNov 22Sale155.73128,72620,046,500260,691Nov 23 01:53 PM
McMullen Michael R.CEO and PresidentNov 16Option Exercise40.806,775276,420277,671Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 16Sale148.196,7751,003,987270,896Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 09Option Exercise40.806,775276,420198,133Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 09Sale138.316,775937,050191,358Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 02Option Exercise40.806,775276,420198,133Nov 04 10:54 AM
McMullen Michael R.CEO and PresidentNov 02Sale140.616,775952,633191,358Nov 04 10:54 AM
Tang MichaelSVP, General Counsel, and Sec.Nov 01Sale139.503,600502,20043,280Nov 03 09:52 AM
McMullen Michael R.CEO and PresidentOct 26Option Exercise40.806,775276,420198,133Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 26Sale134.436,775910,763191,358Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 19Option Exercise40.806,775276,420198,133Oct 21 05:01 PM
McMullen Michael R.CEO and PresidentOct 19Sale130.116,775881,495191,358Oct 21 05:01 PM
MCDONNELL PADRAIGSr. Vice PresidentSep 28Sale122.892,103258,43813,217Sep 30 10:34 AM
Thaysen JacobSr. Vice PresidentSep 09Sale137.455,839802,57182,934Sep 13 10:19 AM
MCDONNELL PADRAIGSr. Vice PresidentSep 08Sale134.332,506336,64115,320Sep 09 03:05 PM
MCDONNELL PADRAIGSr. Vice PresidentJun 30Sale118.621,000118,62517,826Jul 01 02:48 PM
Thaysen JacobSr. Vice PresidentJun 02Sale127.435,879749,17988,737Jun 06 01:26 PM
Tang MichaelSVP, General Counsel, and Sec.Mar 18Sale136.211,210164,81446,829Mar 21 05:16 PM
Grau DominiqueSenior Vice PresidentDec 29Sale161.003,669590,70985,405Dec 30 07:21 PM
McMullen Michael R.CEO and PresidentDec 20Sale148.82123,45918,373,168191,187Dec 21 02:36 PM